The Global Cancer Diagnostics Device Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.
Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage.
Scope of the Report:
A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical companies are shifting their focus from drug development to cancer diagnostic devices so that they can help in diagnosing, monitoring, and administering drugs through the cancer treatment process. These devices play a key role in helping pharmaceutical companies develop specific drugs to treat cancer. One such example is Roche’s cobas EGFR mutation test, which diagnoses head and neck cancers. Increased investment in diagnostic device development will boost market growth by the end of 2020.
The Americas dominated the global cancer diagnostic devices market in 2015 with a market share of close to 53% and will retain its leadership position until the end of 2020. The Americas region has several well-known medical facilities, which focus on targeted therapeutic methods to treat different types of cancers. The availability of a large number of medical facilities in the Americas will lead to the strong growth of this market over the forecast period.
The worldwide market for Cancer Diagnostics Device is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.
This report focuses on the Cancer Diagnostics Device in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Abbott Diagnostics
- Agilent Technologies
- BD
- bioMérieux
- Qiagen
- Roche Diagnostics
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Companion Diagnostics
- Molecular Diagnostics
Market Segment by Applications, can be divided into
- Lung
- Breast
- Colorectal
- Prostate
- Cervical
- Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Diagnostics Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Diagnostics Device, with price, sales, revenue and global market share of Cancer Diagnostics Device in 2017 and 2018.
Chapter 3, the Cancer Diagnostics Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Diagnostics Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Cancer Diagnostics Device market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Cancer Diagnostics Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.